Technology | October 13, 2009
SenoRx Extends EnCor Breast Biopsy to MRI

October 13, 2009 - SenoRx extends the EnCor breast biopsy product line into the MRI arena by offering grid and pillar/post compatibility in the same EnCor MRI product.

SenoRx will show at RSNA 2009, in the North building, booth 7317, the low-profile of the EnCor MRI handpiece, which allows access to even the top most area of the MRI grid. The most significant feature of the MRI product line is the MRI visible obturator, VisiLoc. The VisiLoc obturator provides high visibility through a safe, positive-contrast mechanism that reinforces physician confidence in targeting with each procedure.

Also on display is the StarchMark Biopsy Site Marker, the only breast biopsy marker to use polysaccharide (starch) pellets to help manage and control bleeding. Pellets are essentially resorbed in approximately 2 weeks, which includes a stainless steel wireform in the center pellet for long-term radiographic marking of the biopsy site.

For more information: www.senorx.com


Additional Content

News | Women's Health

Oct. 15, 2026— SimBioSys has announced U.S. Food and Drug Administration (FDA) 510(k) clearance of TumorSight Risk, its ...

Time October 19, 2026
arrow
News | Magnetic Resonance Imaging (MRI)

July 7, 2026 — Imagion Biosystems, Ltd. recently announced it has renewed and extended its collaboration agreement with ...

Time July 07, 2026
arrow
News | Mammography

June 23, 2026 — Using artificial intelligence (AI), researchers found that image-based risk scores for breast cancer ...

Time June 24, 2026
arrow
Feature | Magnetic Resonance Imaging (MRI)

The majority of MRI scanners require about 1,500 liters of liquid helium to operate, but geopolitical unrest is putting ...

Time June 17, 2026
arrow
News | Breast Imaging

April 15, 2026 — QT Imaging Holdings, Inc. has launched its QTI Imaging-Olea Viewer, developed in collaboration with ...

Time April 15, 2026
arrow
Subscribe Now